Suppression of transforming growth factor β signalling aborts caerulein induced pancreatitis and eliminates restricted stimulation at high caerulein concentrations

Gut

Volumn 56, Issue 5, 2007, Pages 685-692

  Wildi, Stefan ^b,g   Kleeff, Jörg ^c   Mayerle, Julia ^b,h   Zimmermann, Arthur ^d   Böttinger, Erwin P ^e   Wakefield, Lalage ^f   Büchler, Markus W ^c   Friess, Helmut ^c   Korc, Murray ^a,b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF ZURICH   (Switzerland)

^h UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; CERULETIDE; CHOLECYSTOKININ; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL LIPASE; TRYPSINOGEN ACTIVATION PEPTIDE;

ACUTE PANCREATITIS; AMYLASE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME RELEASE; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PANCREAS ACINUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION;

ACUTE DISEASE; AMYLASES; ANIMALS; BLOTTING, NORTHERN; CAERULEIN; EDEMA; LIGANDS; LIPASE; MICE; MICE, TRANSGENIC; OLIGOPEPTIDES; PANCREATIC DISEASES; PANCREATITIS; RECEPTORS, CHOLECYSTOKININ; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 34247482269     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.105833     Document Type: Article

References (48)

1. Steer ML. Classification and pathogenesis of pancreatitis. Surg Clin North Am 1989;69:467-80.
2. Lampel M, Kern H. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretogogue. Virchows Arch A Pathol Anat Histol 1977;373:97-117.
3. Niederau C, Ferrell LD, Grendell JH. Careulein-induced acute pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology 1985;88:1192-204.
4. Hofbauer B, Saluja AK, Lerch M, et al. Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats. Am J Physiol 1998;275:G352-62.
5. Grady T, Mah'moud M, Otani T, et al. Zymogen proteolysis within the pancreatic acinar cell is associated with cellular injury. Am J Physiol 1998;275:G1010-17.
6. Massagué J. TGF-β signal transduction. Annu Rev Biochem 1998;67:753-91.
7. Menke A, Yamaguchi H, Gress TM, et al. Extracellular matrix is reduced by inhibition of transforming growth factor β1 in pancreatitis in the rat. Gastroenterology 1997;113:295-303.
8. Van Laetham JL, Robberecht P, Résibois A, et al. Transforming growth factor β promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology 1996;110:576-82.
9. Riesle E, Friess H, Zhao L, et al. Increased expression of transforming growth factor βs after acute oedematous pancreatitis in rats suggests a role in pancreatic repair. Gut 1997;40:73-9.
10. Di Mola FF, Friess H, Martignoni ME, et al. Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg 1999;230:63-71.
11. Sandoval D, Gukovskaya A, Reavy P, et al. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology 1996;111:1081-91.
12. Böttinger EP, Jakubczac JL, Roberts ISD, et al. Expression of a dominant-negative mutant TGF-β type II receptor in transgenic mice reveals essential roles for TGF-β in regulation of growth and differentiation in the exocrine pancreas. EMBO J 1997;16:2621- 33.
13. Jurkowska G, Grondin G, Morisset J. Involvement of endogenous cholecystokinin in pancreatic regeneration after caerulein-induced acute pancreatitis. Pancreas 1992;7:295-304.
14. Jurkowska G, Grondin G, Masse S, et al. Soybean trypsin inhibitor and caerulein accelerate recovery of caerulein-induced pancreatitis in rats. Gastroenterology 1992;102:550-62.
15. Konturek PC, Dembinski A, Warzecha Z, et al. Expression of transforming growth factor beta 1 and epidermal growth factor in caerulein-induced pancreatitis in rat. J Physiol Pharmacol 1997;48:59-72.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
17. Korc M, Chandrasekar B, YamanakaY, et al. Overexpression of the epidermal growth factor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992;90:1352-60.
18. Hofbauer B, Friess H, Weber A, et al. Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the rat. Gut 1996;38:753-8.
19. Heath DI, Wilson C, Gudgeon AM, et al. Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis. Gut 1994;35:1311-15.
20. Grady T, Liang P, Ernst SA, et al. Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology 1997;113:1966-75.
21. Williams JA, Korc M, Dormer RL. Action of secretogogues on a new preparation of functionally intact, isolated pancreatic acini. Am J Physiol 1978;235:517-24.
22. Korc M. Regulation of pancreatic protein synthesis by cholecystokinin and calcium. Am J Physiol 1982;243:G69-75.
23. Barlas N, Jensen RT, Gardner JD. Cholecystokinin-induced restricted stimulation of pancreatic enzyme secretion. Am J Physiol 1982;242:G464-9.
24. Burnham DB, Williams JA. Effects of high concentrations of secretogogues on the morphology and secretory activity of the pancreas: a role for microfilaments. Cell Tissue Res 1982;222:201-12.
25. O'Konski MS, Pandol SJ. Effects of caerulein on the apical cytoskeleton of the pancreatic acinar cell. J Clin Invest 1990;86:1649-57.
26. Jungermann J, Lerch MM, Weidenbach H, et al. Disassembly of rat pancreatic acinar cell cytoskeleton during supramaximal secretogogue stimulation. Am J Physiol 1995;268:G328-38.
27. Bi Y, Williams JA. Receptor biology and signal transduction in pancreatic acinar cells. Curr Opin Gastroenterol 2004;20:427-34.
28. Krüger B, Albrecht E, Lerch MM. The role of intracellular calcium signaling in premature protease activation and the onset of pancreatitis. Am J Pathol 2000;157:43-50.
29. Halangk W, Krüger B, Ruthenbürger M, et al. The role of trypsin in premature, intrapancreatic trypsinogen activation and inactivation of trypsin activity. Am J Physiol Gastrointest Liver Physiol 2002;282:G367-74.
30. Saluja AK, Donovan EA, Yamanaka K, et al. Caerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 1997;113:304-10.
31. Luthen R, Niederau C, Grendell JH. Intrapancreatic zymogen activation and levels of ATP and glutathion during caerulein pancreatitis in rats. Am J Physiol 1995;268:G592-604.
32. Otani T, Chepilko MS, Grendell JH, et al. Codistribution of TAP and the granule membrane protein GRAMP-92 in rat caerulein-induced pancreatitis. Am J Physiol 1998;275:G999-1009.
33. Yoo BM, Yeo M, Oh TY, et al. Amelioration of pancreatic fibrosis in mice with defective TGF-beta signaling. Pancreas 2005;30:e71-9.
34. Nagashio Y, Ueno H, Imamura M, et al. Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice. Lab Invest, 2004 Dec, 84:1610-18.
35. Kameya S, Hayakawa T, Kameya A, et al. Clinical value of routine isoamylase analysis of hyperamylasemia. Am J Gastroenterol 1986;81:358-64.
36. Brandes ME, Mai UE, Ohura K, et al. Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta. J Immunol 1991;147:1600-6.
37. Fava RA, Olsen MJ, Postlethwaite AE, et al. Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med 1991;173:1121-32.
38. Drake WT, Issekutz AC. Transforming growth factor-beta 1 enhances polymorphonuclear leucocyte accumulation in dermal inflammation and transendothelial migration by a priming action. Immunology 1993;78:197-204.
39. Moralejo DH, Ogino T, Kose H, et al. Genetic verification of the role of CCK-AR in pancreatic proliferation and blood glucose and insulin regulation using a congenic rat carrying CCK-AR null allele. Res Commun Mol Pathol Pharmacol 2001;109:259-74.
40. Kikuchi Y, Shimosegawa T, Moriizumi S, et al. Transgenic copper/zinc-superoxide dismutase ameliorates caerulein-induced pancreatitis in mice. Biochem Biophys Res Commun 1997;233:177-81.
41. Bhatia M, Saluja AK, Hofbauer B, et al. Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci USA 1998;95:4760-5.
42. Halangk W, Lerch MM, Brandt-Nedelev B, et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 2000;106:773-81.
43. Hahm KB, Im YH, Lee C, et al. Loss of TGF-beta signaling contributes to autoimmune pancreatitis. J Clin Invest 2000;105:1057-65.
44. Giraud AS. Lessons from genetically engineered models X. Trefoil peptide and EGF receptor/ligand transgenic mice. Am J Physiol Gastrointest Liver Physiol 2000;278:G501-6.
45. Ishihara T, Hayasaka A, Yamaguchi T, et al. Immunohistochemical study of transforming growth factor-beta 1, matrix metalloproteinase-2,9, tissue inhibitors of metalloproteinase-1,2, and basement membrane components at pancreatic ducts in chronic pancreatitis. Pancreas 1998;17:412-18.
46. Friess H, Duarte R, Kleeff J, et al. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings. Surgery 1998;124:79-86.
47. Jamdar S, Al-Mowallad AF, Kumar S, et al. Differential kinetics of plasma CD105 and transforming growth factor beta expression early in human acute pancreatitis. Pancreas 2006;32:152-8.
48. Halder SK, Beauchamp RD, Datta PK. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia 2005;7:509-21.